Icon
+91 94997 68112
Login Register

Selzentry - (150,300 mg; Tablet, Oral)

Maraviroc VIIV Healthcare
150,300 mg; Tablet, Oral
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
Less Than 5
Less Than 5
Less Than 5
Used to treat CCR5-tropic human immunodeficiency virus (HIV) type 1.
Yes
** ********** *****. ***** *** ********* **** ******* ********** *** **** ***. ******* *** *, **** ; ******* *** *, **** ; ******* *** **, **** ; ******* *** **, ****. ** ****** **** **** *** *** ***** ** ******* *** *, **** *** **** ** *** ***** ** ***** ***** ******** *******, **** ** ********** *** *******. ************ ** ******* *** ** ******** ******* **** ** *, ****.****** & ****** **** ********* ******** *** **** ** ** *** *** ********* ** *** *** ******, ******** ****** ** ********* ****** ** ** ****. (*****://***.***.***/*****/****/**-*-****.***)
Selzentry Patent 1 Patent 2 Patent 3
****** *** ********* *** ********* *** *********
****** *** ********* *** ********* *** *********
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** \ ** ** *** ********* ******** ******** ** *** **, ****
****** *** \ ** ** *** ********* ********* ******** ****** **** ********
  1. : ** ********** *****
  2. *** *, **** : * **** ** *** ***** *** ***** *** * *** *********, ***** **** ***** *********.
  3. *** *, **** : ****** ******** ********* ********.
  4. *** **, **** : ****** ******** ********* ********.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.